Skip to content

Tilray Brands, Inc. TLRY Interest Income (Expense), Nonoperating

Interest Income (Expense), Nonoperating at other companies

Cencora logo
CencoraCOR
-$140.46M-35.1%
Boston Beer logo
Boston BeerSAM
Cronos Group logo
Cronos GroupCRON
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX

Other financials

Income statement

See full
Revenue$206.7M+11.3%
Gross profit$55.0M+5.7%
Operating income-$26.4M+96.5%
Net income-$26.6M+96.6%
EPS (diluted)-$0.24+97.2%

Balance sheet

See full
Cash & equivalents$204.6M+2.3%
Total debt$211.4M-6.9%
Total equity$1.6B-42.9%
Total assets$2.1B-39.0%

Cash flow

See full
Operating cash flow-$21.9M-281%
CapEx$6.3M-34.8%
Free cash flow-$19.1M

Valuation

See full
Market cap$538.85M+47.3%
Enterprise value$545.59M+46.8%
P/S0.6×+0.2×

Profitability

See full
Gross margin30.9%+2.9pp
Operating margin-103.5%-198pp
Net margin-156.1%+89.5pp
FCF margin-15.5%

Returns & leverage

See full
Return on equity-62.5%-1,636pp
Debt / equity0.1×+0.1×
Current ratio2.8×+0.2×

Where this comes from

Reported directly by Tilray Brands, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.

The official record: Tilray Brands, Inc.’s 10-Q, filed April 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tilray Brands, Inc.'s interest income (expense), nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tilray Brands, Inc.'s interest income (expense), nonoperating?
Tilray Brands, Inc. (TLRY) reported interest income (expense), nonoperating of -$4.97M in Q4 2025.
How has Tilray Brands, Inc.'s interest income (expense), nonoperating changed year-over-year?
Tilray Brands, Inc.'s interest income (expense), nonoperating increased by 40.7% year-over-year, from -$8.38M to -$4.97M.
What is the long-term trend for Tilray Brands, Inc.'s interest income (expense), nonoperating?
Over 3 years (2021 to 2024), Tilray Brands, Inc.'s interest income (expense), nonoperating has grown at a 12.7% compound annual growth rate (CAGR), from -$25.43M to -$36.43M.